Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Journey Medical | DERM | Nov 26, 2024 | 5.55 | -3.31 |
Jowell Global | JWEL | Nov 26, 2024 | 3.39 | -0.88 |
JOYY ADR | YY | Nov 26, 2024 | 35.00 | +0.72 |
JP Morgan Chase | JPM | Nov 26, 2024 | 249.97 | -0.13 |
JP Morgan Chase & Co EE Pref | JPM-C | Nov 26, 2024 | 25.36 | -0.51 |
JP Morgan Chase & Co GG Pref | JPM-J | Nov 26, 2024 | 22.13 | -1.12 |
JP Morgan Chase & Co Ser DD Pref | JPM-D | Nov 26, 2024 | 25.10 | -0.75 |
JPMorgan Nasdaq Equity Premium Income ETF | JEPQ | Nov 26, 2024 | 56.97 | +0.49 |
Jumia Technologies ADR | JMIA | Nov 26, 2024 | 3.96 | -3.65 |
Junee Limited - Ordinary Shares | JUNE | Nov 26, 2024 | 4.68 | -1.68 |
Junior Gold Miners ETF Market Vectors | GDXJ | Nov 26, 2024 | 46.67 | -0.32 |
Juniper Networks | JNPR | Nov 26, 2024 | 36.02 | -0.50 |
JVSPAC Acquisition | JVSAU | Nov 26, 2024 | 10.90 | 0.00 |
JVSPAC Acquisition | JVSA | Nov 26, 2024 | 10.39 | 0.00 |
JX Luxventure | JXJT | Nov 26, 2024 | 1.30 | +6.56 |
Kadant | KAI | Nov 26, 2024 | 422.93 | +1.02 |
Kairos Pharma | KAPA | Nov 26, 2024 | 1.70 | 0.00 |
Kairous Acquisition | KACL | Nov 26, 2024 | 12.46 | -0.32 |
Kaiser Aluminium | KALU | Nov 26, 2024 | 81.68 | -2.51 |
Kaival Brands Innovations Group | KAVL | Nov 26, 2024 | 0.73 | +1.22 |
Kaixin Holdings | KXIN | Nov 26, 2024 | 1.96 | -1.51 |
Kala Bio | KALA | Nov 26, 2024 | 6.49 | -6.10 |
Kaltura | KLTR | Nov 26, 2024 | 2.17 | -2.69 |
KalVista Pharmaceuticals | KALV | Nov 26, 2024 | 9.98 | -0.89 |
Kamada | KMDA | Nov 26, 2024 | 5.81 | +0.17 |
Kandi Technologies Group | KNDI | Nov 26, 2024 | 1.27 | -2.31 |
Kanzhun ADR | BZ | Nov 26, 2024 | 12.18 | -3.64 |
Karat Packaging | KRT | Nov 26, 2024 | 30.91 | +0.13 |
Karooooo | KARO | Nov 26, 2024 | 41.11 | -0.22 |
Kartoon Studios | TOON | Nov 26, 2024 | 0.66 | -4.83 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.